new digital currency list searches

The merger of Guotai Junan Haitong Securities was approved by the shareholders' meeting, and the merger and reorganization of Guotai Junan and Haitong Securities completed a key step. On the evening of December 13, the two companies simultaneously announced the resolutions of the shareholders' meeting. The merger and reorganization transaction plan and other related proposals were reviewed by the shareholders' meeting and passed by high votes. The merger and reorganization of Guotai Junan and Haitong Securities is the first merger and reorganization of head brokers since the implementation of the new "National Nine Articles". It is also the largest A+H bilateral market merger and the largest integration case of listed brokers in the history of China capital market, and the largest M&A project in international investment banking since 2008, involving multi-business licenses and a number of domestic and foreign listed subsidiaries.Coal stocks fluctuated lower Antai Group fell more than 6%, coal stocks fluctuated lower, Antai Group fell more than 6%, and mountain coal international, Dayou Energy, Shaanxi Black Cat, China Coal Energy and Lu 'an Huaneng followed suit.Asia-Pacific Pharmaceuticals: The new specifications of cefmetazole sodium for injection were approved, and Asia-Pacific Pharmaceuticals announced that the company was approved by National Medical Products Administration, and the new specifications of cefmetazole sodium for injection were 0.5g and 2g, which further enriched the product categories on the basis of the original 1g specifications. The annual sales income of this drug in 2023 was 96.3946 million yuan, accounting for 22.92% of the company's operating income. New specifications are helpful to market promotion and competitiveness improvement, but drug production and sales are affected by policies and market environment, and there are uncertainties.

Ha Sanlian: Four kinds of drugs are planned to win the bid for national centralized procurement. Ha Sanlian announced that the company and its wholly-owned subsidiary Lanxi Pharmaceutical participated in the tenth batch of national centralized procurement of drugs organized by the state. The company's esmolol hydrochloride injection, pentoxifylline injection, potassium chloride injection, and tandospirone citrate tablets of Lanxi Pharmaceutical intend to win the bid for this centralized procurement. If the subsequent purchase contract is signed and implemented, it will help to expand the sales of related products and improve the market share and brand influence. The prices of the above-mentioned drugs are respectively 1.34 yuan for esmolol hydrochloride injection, 0.59 yuan for pentoxifylline injection, 0.16 yuan for potassium chloride injection and 6.56 yuan for tandospirone citrate tablets.The new CEO of Pakistan Stock Exchange said that the exchange is seeking to provide traders with the option of cash settlement of futures trading, and plans to conduct a test before March next year.Musk: Grok can now generate four images at the same time and render them step by step.

Shanghai ranks third in the world! The Global Financial Technology Center Development Index (2024) was released. It was learned from the 6th Shanghai International Forum on Financial Technology that the Shanghai Financial Technology Industry Alliance released the "Global Financial Technology Center Development Index (2024)", which was released for the second consecutive year. The results of this index show that new york, London, Shanghai, Beijing, Shenzhen, Tokyo, Chicago, Hong Kong, Singapore and San Francisco rank among the top ten in the world. The index is mainly composed of indicators such as the development level, development potential and development environment of financial technology, which intuitively reflects the development of financial technology in different cities around the world in quantitative form. Compared with the previous index, the list of the top ten cities remains unchanged, but the gap between the index scores of cities has further narrowed, showing the increasingly fierce competition in the development of financial technology in major cities around the world. (CBN)Huichuan Technology's newly established subsidiary contains a number of AI businesses. The enterprise search APP shows that Beijing Huichuan Technology Co., Ltd. was recently established with Guo Lipeng as the legal representative and a registered capital of 300 million yuan. Its business scope includes: artificial intelligence theory and algorithm software development; Basic resources and technical platform of artificial intelligence; General application system of artificial intelligence; Artificial intelligence application software development, etc. Enterprise investigation shows that the company is wholly owned by Huichuan Technology.Market News: The Bank of Japan will consider not raising interest rates at its next policy meeting.